The National Institutes of Health is beginning a $100 million pilot phase of a project called The Cancer Genome Atlas that aims to unlock all the genetic abnormalities that contribute to cancer, an effort that would exceed the Human Genome Project in complexity but could eventually lead to new diagnostic tests and treatments for the disease.